glp1.how

Hormone replacement therapy (HRT) and GLP-1 medications: an overview

HRT and GLP-1s are different tools that keep coming up together, because the life stages where people reach for hormones — menopause in women, low testosterone in men — are also times of weight and body-composition change. Here's how they relate, who benefits, and how to think about using them together.

Updated Jul 16, 2026

Hormone replacement therapy (HRT) and GLP-1 medications are different tools, but they keep showing up in the same conversation. The reason is timing: the life stages when people reach for hormones — menopause in women, low testosterone in men — are also the stages of weight gain and body-composition change that bring people to a GLP-1.

What "HRT" covers

  • For women: menopausal hormone therapy — estrogen, usually with a progestogen — for menopausal symptoms and bone protection.
  • For men: testosterone replacement therapy (TRT) for diagnosed hypogonadism.

Both replace a hormone the body is short on. Neither is a weight-loss drug, and neither is a GLP-1. That's the single most useful thing to hold onto.

Who benefits (the short version)

  • Women — those with moderate-to-severe menopausal symptoms or a need for bone protection; individualized by timing and personal risk. → see HRT for women and GLP-1 medications.
  • Men — those with genuine hypogonadism; but obesity-related low testosterone is often reversible without TRT. → see HRT for men and GLP-1 medications.

Why GLP-1s are part of the conversation

  • Shared terrain. Menopause and obesity-related low testosterone both involve gaining fat (especially visceral) and losing muscle — the same body-composition problems a GLP-1 addresses through weight loss.
  • Weight loss changes hormones. Losing weight — including on a GLP-1 — tends to raise testosterone in men whose levels were obesity-related. In women, hormone therapy is associated with less visceral fat, though it doesn't preserve muscle and isn't a weight-loss treatment.
  • Complementary, not interchangeable. Some people use a GLP-1 for weight and HRT for hormone symptoms, under medical supervision. Direct evidence on combining them is still limited, so it's individualized.
  • Muscle is the shared caveat. GLP-1 weight loss can cost lean mass for anyone — protein and resistance training are the defense (see the movement and strength guides).

How to approach it

  • Get proper testing and diagnosis before starting any hormone therapy — especially for men, where obesity can mimic hypogonadism.
  • Coordinate GLP-1 and HRT decisions with your clinician(s). They treat different problems and belong in the same care plan, not in competition.
  • Don't treat HRT as a weight-loss tool or a GLP-1 substitute — that's not what it does.

This is general education, not medical advice. Hormone therapy carries individual benefits and risks — decisions belong with your clinician.

hrthormone-therapyglp-1overviewlive-well

Was this helpful?

Common questions

Questions people often ask about this topic.

  • Is HRT a weight-loss treatment?

    No. HRT — menopausal hormone therapy for women, testosterone therapy for men — replaces a hormone the body is short on. It's not a weight-loss drug and not a GLP-1, though the life stages when people use it overlap with weight and body-composition changes.

  • How are HRT and GLP-1 medications related?

    They share terrain: menopause and obesity-related low testosterone both involve gaining fat and losing muscle — the same problems a GLP-1 addresses through weight loss. And weight loss itself changes hormones (raising testosterone in men). They're complementary, not interchangeable.

  • Should men and women approach HRT differently with a GLP-1?

    Yes. For women it's mainly about menopausal symptoms and bone protection; for men it's about whether low testosterone is true hypogonadism or the reversible, obesity-related kind. See the dedicated pages for each.

  • Do I need testing before combining HRT and a GLP-1?

    Get proper testing and diagnosis before starting any hormone therapy — especially men, since obesity can mimic low testosterone on a lab test. Then coordinate GLP-1 and HRT decisions with your clinician(s).

Evidence: For & Against

Both sides of the topic, so you can weigh the evidence yourself.

2Supporting

Related terms

  • Hormone replacement therapy (HRT) — Treatment that replaces a hormone the body no longer produces in adequate amounts — most commonly estrogen (usually with a progestogen) for menopausal women, or testosterone for men with hypogonadism. It is not a weight-loss treatment and is separate from GLP-1 medications.
  • Testosterone replacement therapy (TRT) — Replacing testosterone in men who have hypogonadism (clinically low testosterone plus symptoms), delivered as a gel, injection, patch, or pellet. It is for a specific diagnosis, not a default treatment for the reversible low testosterone that often accompanies obesity.
  • Menopausal hormone therapy (MHT) — Estrogen, usually combined with a progestogen (when the uterus is present), used to relieve menopausal symptoms such as hot flashes and to protect bone. Often just called 'HRT.' It is associated with less visceral fat but is not a weight-loss treatment.
  • SHBG (sex hormone-binding globulin) — A protein that binds and transports sex hormones (including testosterone) in the blood. Obesity lowers SHBG, which reduces measured total testosterone and is a major reason obesity can look like low testosterone on a lab test.

Related guides